These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 8108467)
41. ET(B) receptor blockade potentiates the pressor response to big endothelin-1 but not big endothelin-2 in the anesthetized rabbit. Gratton JP; Rae GA; Bkaily G; D'Orléans-Juste P Hypertension; 2000 Mar; 35(3):726-31. PubMed ID: 10720586 [TBL] [Abstract][Full Text] [Related]
42. Inhibition of big ET-1-induced pressor response by an orally active dual inhibitor of endothelin-converting enzyme and neutral endopeptidase 24.11. Trapani AJ; De Lombaert S; Kuzmich S; Jeng AY J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S69-71. PubMed ID: 8587471 [TBL] [Abstract][Full Text] [Related]
43. Analysis of responses to big endothelin in the hindquarters vascular bed of the cat. Tamura DY; Minkes RK; Bellan JA; McMahon TJ; McNamara DB; Kadowitz PJ Can J Cardiol; 1992 Nov; 8(9):954-60. PubMed ID: 1486546 [TBL] [Abstract][Full Text] [Related]
44. Phosphoramidon inhibits the conversion of intracisternally administered big endothelin-1 to endothelin-1. Shinyama H; Uchida T; Kido H; Hayashi K; Watanabe M; Matsumura Y; Ikegawa R; Takaoka M; Morimoto S Biochem Biophys Res Commun; 1991 Jul; 178(1):24-30. PubMed ID: 2069564 [TBL] [Abstract][Full Text] [Related]
45. Attenuation of ischemic acute renal failure by phosphoramidon in rats. Vemulapalli S; Chiu PJ; Chintala M; Bernardino V Pharmacology; 1993 Sep; 47(3):188-93. PubMed ID: 8415869 [TBL] [Abstract][Full Text] [Related]
46. Radioimmunoassay evidence that the pressor effect of big endothelin-1 is due to local conversion to endothelin-1. Corder R; Vane JR Biochem Pharmacol; 1995 Jan; 49(3):375-80. PubMed ID: 7857324 [TBL] [Abstract][Full Text] [Related]
47. Effects of phosphoramidon on endothelin-1 and big endothelin-1 production in human aortic endothelial cells. Matsumura Y; Tsukahara Y; Kojima T; Murata S; Murakami A; Takada K; Takaoka M; Morimoto S Biol Pharm Bull; 1995 Mar; 18(3):401-6. PubMed ID: 7550091 [TBL] [Abstract][Full Text] [Related]
48. Presence of a phosphoramidon-sensitive endothelin-converting enzyme which converts big-endothelin-1, but not big-endothelin-3, in the rat vas deferens. Télémaque S; D'Orléans-Juste P Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):505-7. PubMed ID: 1766477 [TBL] [Abstract][Full Text] [Related]
49. CGS 34226, a thiol-based dual inhibitor of endothelin converting enzyme-1 and neutral endopeptidase 24.11. Jeng AY; Savage P; Beil ME; Bruseo CW; Hoyer D; Fink CA; Trapani AJ Clin Sci (Lond); 2002 Aug; 103 Suppl 48():98S-101S. PubMed ID: 12193064 [TBL] [Abstract][Full Text] [Related]
50. ETA receptor-mediated responses to endothelin-1 and big endothelin-1 in the rat kidney. Pollock DM; Opgenorth TJ Br J Pharmacol; 1994 Mar; 111(3):729-32. PubMed ID: 8019752 [TBL] [Abstract][Full Text] [Related]
51. Contraction to big endothelin-1, big endothelin-2 and big endothelin-3, and endothelin-converting enzyme inhibition in human isolated bronchi. Yap EY; Battistini B; McKay KO Br J Pharmacol; 2000 Jan; 129(1):170-6. PubMed ID: 10694217 [TBL] [Abstract][Full Text] [Related]
52. Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1-39) in vivo and conversion of big endothelin-1-(1-39) to endothelin-1-(1-21) in vitro. McMahon EG; Palomo MA; Moore WM; McDonald JF; Stern MK Proc Natl Acad Sci U S A; 1991 Feb; 88(3):703-7. PubMed ID: 1992461 [TBL] [Abstract][Full Text] [Related]
53. The membranes of cultured rat brain astrocytes contain endothelin-converting enzyme activity. Deschepper CF; Houweling AD; Picard S Eur J Pharmacol; 1995 Feb; 275(1):61-6. PubMed ID: 7774663 [TBL] [Abstract][Full Text] [Related]
54. Functional evidence for the presence of a phosphoramidon-sensitive enzyme in rat brain that converts big endothelin-1 to endothelin-1. Hashim MA; Tadepalli AS Life Sci; 1991; 49(24):PL207-11. PubMed ID: 1943480 [TBL] [Abstract][Full Text] [Related]
55. Local formation and degradation of endothelin-1 in guinea pig airway tissues. Noguchi K; Fukuroda T; Ikeno Y; Hirose H; Tsukada Y; Nishikibe M; Ikemoto F; Matsuyama K; Yano M Biochem Biophys Res Commun; 1991 Sep; 179(2):830-5. PubMed ID: 1898406 [TBL] [Abstract][Full Text] [Related]
56. Big endothelin-1-induced sudden death is inhibited by phosphoramidon in mice. Matsuura A; Okumura H; Ashizawa N; Kobayashi F Life Sci; 1992; 50(21):1631-8. PubMed ID: 1579051 [TBL] [Abstract][Full Text] [Related]
57. The effects of phosphoramidon on the regional haemodynamic responses to human proendothelin [1-38] in conscious rats. Gardiner SM; Compton AM; Kemp PA; Bennett T Br J Pharmacol; 1991 Aug; 103(4):2009-15. PubMed ID: 1912989 [TBL] [Abstract][Full Text] [Related]
58. [Phe22]-big endothelin-1[19-37]: a new and potent inhibitor of the endothelin-converting enzyme. Claing A; Neugebauer W; Yano M; Rae GA; D'Orléans-Juste P J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S72-4. PubMed ID: 8587472 [TBL] [Abstract][Full Text] [Related]
59. Phosphoramidon attenuates big endothelin-1-induced vasoconstriction in canine stomach. Wood JG; Yan ZY; Davis JM; Cheung LY Am J Physiol; 1994 Feb; 266(2 Pt 1):G311-7. PubMed ID: 8141304 [TBL] [Abstract][Full Text] [Related]
60. Effect of phosphoramidon on big endothelin-2 conversion into endothelin-2 in human renal adenocarcinoma (ACHN) cells. Analysis of endothelin-2 biosynthetic pathway. Yorimitsu K; Shinmi O; Nishiyama M; Moroi K; Sugita Y; Saito T; Inagaki Y; Masaki T; Kimura S FEBS Lett; 1992 Dec; 314(3):395-8. PubMed ID: 1468574 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]